PERCEPTIVE ADVISORS LLC

Position in LONA — LeonaBio, Inc.

CIK 1224962 NEW YORK, NY

Position in LONA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,087,169

-$2,026,661 QoQ

Shares Held

1,859,322

0.0% QoQ

Ownership

19.7%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

of 44 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. LONA ranks #46 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$681,627,752
2	SYRE	Spyre Therapeutics, Inc.	4,319,496	$383,484,854
3	CELC	Celcuity Inc.	3,197,200	$334,491,064
4	ASND	Ascendis Pharma A/S	1,163,721	$310,387,665
5	RYTM	Rhythm Pharmaceuticals, Inc.	2,586,295	$287,156,333
6	ROIV	Roivant Sciences Ltd.	8,085,461	$286,144,464
7	RLAY	Relay Therapeutics, Inc.	14,106,187	$263,926,758
8	TVTX	Travere Therapeutics, Inc.	3,752,574	$213,183,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-08-22	$14,520,062	1,889,403	+0.4%	Shares	Sole	2026-08-25
2026-06-30	$17,087,169	1,859,322	0.0%	Shares	Sole	2026-08-14
2026-05-05	$18,127,223	1,882,370	+1.2%	Shares	Sole	2026-05-07
2026-03-31	$19,113,830	1,859,322	0.0%	Shares	Sole	2026-05-29
2026-01-16	$11,341,864	1,859,322	0.0%	Shares	Sole	2026-01-16
2025-12-31	$14,075,067	1,859,322	+244.1%	Shares	Sole	2026-02-17
2025-12-23	$13,963,508	1,859,322	+244.1%	Shares	Sole	2025-12-23
2025-12-18	$3,630,789	540,296	—	Shares	Sole	2025-12-22
2025-09-30	$2,236,825	540,296	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.